Omalizumab

Cross-source consensus on Omalizumab from 1 sources and 1 claims.

1 sources · 1 claims

Uses

Highlighted claims

A subgroup of 67 patients received both omalizumab and benralizumab in the trial. — Brazilian elimination of mother-to-child HIV transmission: lessons for large-scale global health systems